Initial treatment phase (weeks 14): During the starting dose of 0.25 mg weekly, patients commonly experience mild to moderate nausea, occasional sulphur burps, and changes in bowel habits
Accessed 20 Nov 2021 Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
What began as a diabetes treatment story has rapidly evolved into a broader metabolic health transformation
The volume of diluent used determines the final concentration, which in turn affects stability and dosing convenience
Amphotericin B: side effects and toxicity
If you have coverage through an Aetna Medicaid plan, coverage varies by state, so its important to check with your specific plan for more information about coverage and costs